10.1007/s00429-014-0714-z Summary Keywords GLP-1, obesity, diabetes, CNS, insulin Citation Heppner KM and Perez-Tilve D (2015) GLP-1 based therapeutics: simultaneously combating T2DM and obesity
Lee TH, Hoover RL, Williams JD, et al
Discuss Your Goals: Meet with an expert clinician who will assess your health needs and create a plan just for you
History of pancreatitis requires careful evaluation
B12 adequacy is associated with better cognitive aging outcomes, and the combination of neural anti-inflammatory effects from GLP-1R activation and neuroprotective effects from B12 creates a complementary pair even at doses where weight loss is not the goal
Tesamorelin: Metabolic fat reduction, specifically visceral and abdominal fat